{"nct_id":"NCT04442022","title":"A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2020-09-03","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["KPTI"]}